Published in Antimicrob Agents Chemother on June 01, 1993
Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum. J Clin Microbiol (1994) 1.31
Activities of azithromycin and clarithromycin against nontuberculous mycobacteria in beige mice. Antimicrob Agents Chemother (1994) 0.89
Mycobacterium malmoense in Italy: the modern Norman invasion? Eur J Epidemiol (1997) 0.81
Mycobacterium malmoense bacteremia in two AIDS patients. J Clin Microbiol (1996) 0.79
Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man. BMJ Case Rep (2012) 0.75
Pulmonary Infection Due to Mycobacterium malmoense in a Patient with Crohn Disease. Can J Hosp Pharm (2009) 0.75
Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis (1977) 11.20
Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrob Agents Chemother (1985) 2.07
Pulmonary infection with Mycobacterium malmoense--a review of treatment and response. Tubercle (1985) 1.99
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother (1982) 1.89
Infections with Mycobacterium malmoense in England and Wales. Tubercle (1979) 1.74
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Eur J Clin Microbiol (1987) 1.72
Mycobacterium malmoense infection in HIV positive patients. J Infect (1991) 1.64
Mycobacterium malmoense in the north-east of England. Tubercle (1985) 1.51
Mycobacterium malmoense infections in Scotland: an increasing problem. Thorax (1987) 1.17
Studies on the mechanisms of the synergistic effects of ethambutol and other antibacterial drugs on Mycobacterium avium complex. Acta Leprol (1989) 1.16
Chemotypes of Mycobacterium malmoense based on glycolipid profiles. J Clin Microbiol (1991) 1.16
Mycobacterium malmoense: an easily missed pathogen. J Clin Microbiol (1991) 1.05
Ethambutol: a key for Mycobacterium avium complex chemotherapy? Am Rev Respir Dis (1989) 1.01
Pulmonary disease due to Mycobacterium malmoense. J Clin Microbiol (1984) 1.01
Pulmonary disease caused by Mycobacterium malmoense. Am Rev Respir Dis (1987) 1.01
In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex. J Antimicrob Chemother (1989) 0.99
Pulmonary disease caused by Mycobacterium malmoense. Comments on the possible origin of infection and methods for laboratory diagnosis. Tubercle (1991) 0.87
[Mycobacterium malmoense in the Federal Republic of Germany]. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.81
Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid. Eur J Clin Microbiol Infect Dis (1992) 0.80
[Diagnosis and treatment of pulmonary infection due to Mycobacterium malmoense]. Schweiz Med Wochenschr (1991) 0.80
Increased growth of Mycobacterium malmoense in vitro in the presence of isoniazid. Eur J Clin Microbiol Infect Dis (1991) 0.80
[Pulmonary infection caused by a rare mycobacterium, Mycobacterium malmoënse]. Rev Mal Respir (1987) 0.78
Mycobacterium malmoense--report of a case in Switzerland. Respiration (1987) 0.78
Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet (1982) 3.64
Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet (1982) 3.39
Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol (2001) 3.12
Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli. Lancet (1981) 2.76
Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis. Pediatr Clin North Am (1982) 2.33
Bacterial adherence to periurethral epithelial cells in girls prone to urinary-tract infections. Lancet (1978) 2.25
Epidemic outbreaks of acute pyelonephritis caused by nosocomial spread of P fimbriated Escherichia coli in children. J Infect Dis (1984) 2.19
Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods (2001) 2.07
In vitro adhesion of uropathogenic Escherichia coli to human periurethral cells. Infect Immun (1980) 1.98
Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test. Infection (1982) 1.88
Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. Trans R Soc Trop Med Hyg (2001) 1.87
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Eur J Clin Microbiol (1987) 1.72
Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection (1980) 1.66
Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax (1990) 1.65
Carbohydrate receptor structures recognized by uropathogenic E. coli. Scand J Infect Dis Suppl (1982) 1.63
P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection (1983) 1.57
AIDS and Mycobacterium avium serovars in Sweden. Lancet (1989) 1.55
Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis (2001) 1.47
Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau. J Clin Microbiol (1993) 1.47
Urinary tract infections treated with single dose of short-acting sulphonamide. Br Med J (1979) 1.41
Receptors for pyelonephritogenic Escherichia coli in primates. J Urol (1984) 1.34
Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis (1994) 1.33
Molecular epidemiological studies of Mycobacterium bovis infections in humans and animals in Sweden. J Clin Microbiol (1995) 1.33
Mycobacterium tuberculosis Uganda genotype is the predominant cause of TB in Kampala, Uganda. Int J Tuberc Lung Dis (2008) 1.30
Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis (2000) 1.23
Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis (2001) 1.18
The relationship between disease pattern and disease burden by chest radiography, M. tuberculosis Load, and HIV status in patients with pulmonary tuberculosis in Addis Ababa. Infection (2004) 1.16
Studies on the mechanisms of the synergistic effects of ethambutol and other antibacterial drugs on Mycobacterium avium complex. Acta Leprol (1989) 1.16
Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco. avium. Clin Exp Immunol (1996) 1.13
Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden. Int J Tuberc Lung Dis (2008) 1.13
Serovars of Mycobacterium avium complex isolated from patients in Sweden. J Clin Microbiol (1990) 1.13
Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin. Eur J Clin Microbiol Infect Dis (1988) 1.09
P fimbriated Escherichia coli in adults with acute pyelonephritis. J Infect Dis (1985) 1.06
Outbreak of Mycobacterium tuberculosis infection among captive Asian elephants in a Swedish zoo. Vet Rec (2005) 1.06
Mycobacterium malmoense: an easily missed pathogen. J Clin Microbiol (1991) 1.05
Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis (2000) 1.04
Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau. Tuber Lung Dis (1993) 1.03
Ethambutol: a key for Mycobacterium avium complex chemotherapy? Am Rev Respir Dis (1989) 1.01
Periurethral anaerobic microflora of healthy girls. J Clin Microbiol (1979) 1.01
Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin Infect Dis (1995) 0.99
In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex. J Antimicrob Chemother (1989) 0.99
P-fimbriae of pyelonephritogenic Escherichia coli: significance for reflux and renal scarring-a hypothesis. Infection (1983) 0.98
Occurrence of P-fimbriated Escherichia coli in patients with bacteremia. Eur J Clin Microbiol (1985) 0.98
Influence of age on faecal carriage of P-fimbriated Escherichia coli and other gram-negative bacteria in hospitalized neonates. J Hosp Infect (1988) 0.97
The use of biochemical markers, serotype and fimbriation in the detection of Escherichia coli clones. J Gen Microbiol (1987) 0.97
P-fimbriated Escherichia coli in children with acute cystitis. Acta Paediatr Scand (1987) 0.95
P-fimbriae receptors in patients with chronic pyelonephritis. J Urol (1988) 0.95
Gammadelta+ and CD4+ alphabeta+ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts. Clin Exp Immunol (1998) 0.94
Diagnosis of mycobacterial infections by PCR and restriction enzyme digestion. Lett Appl Microbiol (1992) 0.93
A new rapid and simple method for large-scale purification of mycobacterial lipoarabinomannan. FEMS Immunol Med Microbiol (1999) 0.92
Antimycobacterial synergism of clarithromycin and rifabutin. Scand J Infect Dis (1996) 0.91
Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis. Vaccine (2004) 0.90
P-fimbriae studies on the diagnosis and prevention of acute pyelonephritis. Infection (1985) 0.90
Drug resistant tuberculosis in Estonia. Int J Tuberc Lung Dis (1998) 0.89
Pneumocystis carinii is not a major cause of pneumonia in HIV infected patients in Lusaka, Zambia. Trans R Soc Trop Med Hyg (1990) 0.89
Comparison of direct and standardized antibiotic susceptibility testing in bacteriuria. Chemotherapy (1981) 0.88
A biphasic system for primary isolation of mycobacteria compared to solid medium and broth culture. J Med Microbiol (1992) 0.87
Comparison of Mycobacterium avium complex (MAC) strains from pigs and humans in Sweden by random amplified polymorphic DNA (RAPD) using standardized reagents. Vet Microbiol (2001) 0.87
Low urinary counts of P-fimbriated Escherichia coli in presumed acute pyelonephritis. Arch Dis Child (1984) 0.87
Symptomatic recurrent urinary tract infections in patients with renal scarring in relation to fecal colonization with P-fimbriated Escherichia coli. J Urol (1987) 0.86
Density and localization of P-fimbriae-specific receptors on mammalian cells: fluorescence-activated cell analysis. Infection (1983) 0.86
Prevalence of mycobacterium avium complex infection in AIDS patients. Scand J Infect Dis (1991) 0.85
[A man caused a miniepidemic of animal tuberculosis--he infected his wife and cat]. Lakartidningen (1991) 0.85
Susceptibility of mycobacteria to fusidic acid. Eur J Clin Microbiol Infect Dis (1990) 0.85
Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice. Tuberculosis (Edinb) (2005) 0.84
Initiation of clinical pyelonephritis--the role of P-fimbriae-mediated bacterial adhesion. Contrib Nephrol (1984) 0.84
Fecal colonization with pyelonephritogenic Escherichia coli in neonates as a risk factor for pyelonephritis. Eur J Clin Microbiol (1986) 0.83
Pulmonary tuberculosis in Guinea-Bissau: clinical and bacteriological findings, human immunodeficiency virus status and short term survival of hospitalized patients. Tuber Lung Dis (1996) 0.83
A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines. Vaccine (1999) 0.82
Mycobacterium fortuitum complex in Sweden during an 11-year period. Scand J Infect Dis (1997) 0.82
Antibody responses to Escherichia coli J5 lipopolysaccharide and to Salmonella porin in patients with bacteremia. Microb Pathog (1986) 0.82
Mycobacterium avium complex sputum isolates from patients with respiratory symptoms in Guinea-Bissau. J Infect Dis (1996) 0.82
Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children. Scand J Infect Dis (2001) 0.82
Interaction of multiple risk factors in the pathogenesis of experimental reflux nephropathy in the pig. J Urol (1985) 0.82
Synthesis and immunologic characterisation of Mycobacterium tuberculosis lipoarabinomannan specific oligosaccharide-protein conjugates. Vaccine (1999) 0.82
RAPD-PCR and PFGE as tools in the investigation of an outbreak of beta-haemolytic Streptococcus group A in a Swedish hospital. Comp Immunol Microbiol Infect Dis (2003) 0.81
Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies. Vaccine (2000) 0.80
Epidemiological aspects of fecal colonization with P-fimbriated Escherichia coli in neonates. Infection (1987) 0.80
Control of disease progress in Mycobacterium avium-infected AIDS patients. Res Microbiol (1992) 0.80
Increased growth of Mycobacterium malmoense in vitro in the presence of isoniazid. Eur J Clin Microbiol Infect Dis (1991) 0.80
Lack of correlation of P blood group phenotype and renal scarring. Kidney Int (1985) 0.78
Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa. Int J Tuberc Lung Dis (2000) 0.78
Mycobacterium avium complex develop resistance to synergistically active drug combinations during infection. Eur Respir J (1994) 0.78
Direct detection of Mycobacterium tuberculosis in sputum samples from Guinea Bissau by an rRNA target-amplified test system. Tuber Lung Dis (1996) 0.78
The mtp40 gene is not present in Mycobacterium bovis. Tuberculosis (Edinb) (2002) 0.77
Microcalorimetric studies of the initial interaction between antimycobacterial drugs and Mycobacterium avium. J Antimicrob Chemother (1990) 0.77
Fluorescence-activated cell analysis of P-fimbriae receptor accessibility on uroepithelial cells of patients with renal scarring. Eur J Clin Microbiol (1986) 0.76
Pneumococcal bacteraemia in Sweden. Lancet (1997) 0.75
Faecal colonization with P-fimbriated Escherichia coli between 0 and 18 months of age. Epidemiol Infect (1988) 0.75
Quinacrine-induced pleural inflammation in malignant pleurisy: relation between drainage time of pleural fluid and local interleukin-1 beta levels. Respiration (1993) 0.75
Novel approaches to the diagnosis of mycobacterial infections. Eur Respir J (1994) 0.75
[Urinary tract infections--new viewpoints on therapeutic classification and prevention]. Lakartidningen (1977) 0.75
[Views on the treatment of urinary tract infections in children]. Lakartidningen (1979) 0.75
Microbial adhesion and the urinary tract. Lancet (1981) 0.75
Disseminated Mycobacterium malmoense infection in a patient with chronic granulocytic leukaemia. J Intern Med (1993) 0.75
[Pathogenesis of urinary tract infections]. Lakartidningen (1979) 0.75